Richard A. Fair

Insider Reports History

Location
Houston, TX
Signature
/s/ Ben Hohl, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard A. Fair:

Company Role Class Num Shares Value Price $ Report Date Ownership
BELLICUM PHARMACEUTICALS, INC President and CEO, Director Stock Option (right to buy) 400,000 $576,000 $1.44 15 Aug 2022 Direct
Enliven Therapeutics, Inc. PRESIDENT AND CEO, Director Stock Option (right to buy) 875,000 11 Dec 2025 Direct
Clovis Oncology, Inc. Director Stock Option (right to buy) 42,223 10 Jun 2021 Direct

Insider Reports Filed by Richard A. Fair

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ELVN Enliven Therapeutics, Inc. 11 Dec 2025 1 $0 4 PRESIDENT AND CEO, Director 12 Dec 2025, 18:31
ELVN Enliven Therapeutics, Inc. 11 Dec 2025 0 $0 3 PRESIDENT AND CEO, Director 12 Dec 2025, 18:30
/report/000162828022023030-fair-richard-a-2022-08-15 BELLICUM PHARMACEUTICALS, INC 15 Aug 2022 1 +$576,000 4 President and CEO, Director 16 Aug 2022, 17:04
/report/000162828021017225-fair-richard-a-2021-08-16-restatement BELLICUM PHARMACEUTICALS, INC 16 Aug 2021 1 $0 4/A President and CEO, Director 18 Aug 2021, 12:21
/report/000089924321023392-fair-richard-a-2021-06-10 Clovis Oncology, Inc. 10 Jun 2021 1 $0 4 Director 11 Jun 2021, 20:48